Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDUNN: bNAbs and Low-dose Nivolumab for HIV-1 Control
NCT07820813Phase 2Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Sep 2029
01
Overview
A Phase 2 trial of nivolumab in human immunodeficiency virus infection (HIV). Planned start Sep 2026; status: not yet recruiting.
02
Drugs
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT07820813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07820813.